Microglia-derived HIV Nef plus exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides Article

Raymond, AD, Diaz, P, Chevelon, S et al. (2016). Microglia-derived HIV Nef plus exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides . JOURNAL OF NEUROVIROLOGY, 22(2), 129-139. 10.1007/s13365-015-0397-0

cited authors

  • Raymond, AD; Diaz, P; Chevelon, S; Agudelo, M; Yndart-Arias, A; Ding, H; Kaushik, A; Jayant, R Dev; Nikkhah-Moshaie, R; Roy, U; Pilakka-Kanthikeel, S; Nair, MP

sustainable development goals

authors

publication date

  • April 1, 2016

webpage

published in

keywords

  • BBB impairment
  • HUMAN MONOCYTE/MACROPHAGES
  • INFECTED-CELLS
  • INFECTIVITY
  • LOCALIZATION
  • Life Sciences & Biomedicine
  • MICROVESICLES
  • Nanoparticle therapeutics
  • Nef plus exosomes
  • Neurosciences
  • Neurosciences & Neurology
  • PROTEIN
  • SURFACE
  • Science & Technology
  • T-CELLS
  • TIGHT JUNCTION
  • VIRUS TYPE-1 NEF
  • Virology

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 129

end page

  • 139

volume

  • 22

issue

  • 2